Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Godfrey

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Psychiatry|July 10, 2024
Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action"Julia Bornemann, James B Close, Kirran Ahmad, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 15, 2025
EEG is better when cleaning effectively targets artifactsNeil W Bailey, Aron T Hill, Kate Godfrey, et al.
Neuroscience and Biobehavioral Reviews|April 4, 2025
Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical modelsClaudio Agnorelli, Meg Spriggs, Kate Godfrey, et al.
Annals of the New York Academy of Sciences|July 3, 2025
Experienced meditators show greater forward traveling cortical alpha wave strengthsNeil W Bailey, Aron T Hill, Kate Godfrey, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Molecular Psychiatry|January 14, 2025
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settingsClaudio Agnorelli, Alessandra Cinti, Giovanni Barillà, et al.
Comprehensive Psychiatry|July 6, 2025
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyLuca Pellegrini, Naomi A Fineberg, Sorcha O'Connor, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approachClaudio Agnorelli, Joseph Peill, Gabriela Sawicka, et al.
Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Psychiatry|July 10, 2024
Study protocol for "Psilocybin in patients with fibromyalgia: brain biomarkers of action"Julia Bornemann, James B Close, Kirran Ahmad, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 15, 2025
EEG is better when cleaning effectively targets artifactsNeil W Bailey, Aron T Hill, Kate Godfrey, et al.
Neuroscience and Biobehavioral Reviews|April 4, 2025
Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical modelsClaudio Agnorelli, Meg Spriggs, Kate Godfrey, et al.
Annals of the New York Academy of Sciences|July 3, 2025
Experienced meditators show greater forward traveling cortical alpha wave strengthsNeil W Bailey, Aron T Hill, Kate Godfrey, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Molecular Psychiatry|January 14, 2025
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settingsClaudio Agnorelli, Alessandra Cinti, Giovanni Barillà, et al.
Comprehensive Psychiatry|July 6, 2025
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyLuca Pellegrini, Naomi A Fineberg, Sorcha O'Connor, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 21, 2026
Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approachClaudio Agnorelli, Joseph Peill, Gabriela Sawicka, et al.
Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Pageof 2